6534 Stock Overview
Develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
CH Biotech R&D Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$76.40 |
| 52 Week High | NT$93.50 |
| 52 Week Low | NT$71.10 |
| Beta | 0.12 |
| 1 Month Change | -3.17% |
| 3 Month Change | n/a |
| 1 Year Change | -7.95% |
| 3 Year Change | 12.64% |
| 5 Year Change | 72.44% |
| Change since IPO | -5.44% |
Recent News & Updates
Recent updates
Solid Earnings May Not Tell The Whole Story For CH Biotech R&D (TWSE:6534)
Mar 10
CH Biotech R&D (GTSM:6534) Takes On Some Risk With Its Use Of Debt
Apr 05A Look At CH Biotech R&D's (GTSM:6534) Share Price Returns
Mar 18Are CH Biotech R&D Co., Ltd.'s (GTSM:6534) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Feb 09
Returns On Capital At CH Biotech R&D (GTSM:6534) Paint An Interesting Picture
Jan 11Does CH Biotech R&D (GTSM:6534) Have A Healthy Balance Sheet?
Dec 15Tread With Caution Around CH Biotech R&D Co., Ltd.'s (GTSM:6534) 1.8% Dividend Yield
Nov 24Shareholder Returns
| 6534 | TW Chemicals | TW Market | |
|---|---|---|---|
| 7D | 0.5% | 1.7% | 3.9% |
| 1Y | -8.0% | -35.4% | -1.3% |
Return vs Industry: 6534 exceeded the TW Chemicals industry which returned -35.4% over the past year.
Return vs Market: 6534 underperformed the TW Market which returned -1.3% over the past year.
Price Volatility
| 6534 volatility | |
|---|---|
| 6534 Average Weekly Movement | 4.4% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in TW Market | 10.2% |
| 10% least volatile stocks in TW Market | 4.8% |
Stable Share Price: 6534 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6534's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Wen Ren Chen | www.chbio.com |
CH Biotech R&D Co., Ltd., develops and sells biotech-based agrochemicals in Taiwan, the United States, Canada, Australia, Brazil, Argentina, Uruguay, Chile, and internationally. It offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd.
CH Biotech R&D Co., Ltd. Fundamentals Summary
| 6534 fundamental statistics | |
|---|---|
| Market cap | NT$7.94b |
| Earnings (TTM) | NT$476.39m |
| Revenue (TTM) | NT$1.64b |
16.5x
P/E Ratio4.8x
P/S RatioIs 6534 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6534 income statement (TTM) | |
|---|---|
| Revenue | NT$1.64b |
| Cost of Revenue | NT$270.92m |
| Gross Profit | NT$1.36b |
| Other Expenses | NT$888.43m |
| Earnings | NT$476.39m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 06, 2025
| Earnings per share (EPS) | 4.63 |
| Gross Margin | 83.44% |
| Net Profit Margin | 29.12% |
| Debt/Equity Ratio | 22.2% |
How did 6534 perform over the long term?
See historical performance and comparisonDividends
5.4%
Current Dividend Yield88%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 11:55 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CH Biotech R&D Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yenya Kuo | Capital Securities Corporation |
| Hsiu Chi Lin | Masterlink Securities Corp. |